The following categories have been selected based on the existing international literature and taking into account the epidemiological data of the COVID-19 disease epidemic so far in the international arena and in the Republic of Cyprus.
Patients in the following category can work but they can not work in public places and places with very less number of gathering or people.
1. Age over 65 years.
2. Pre-existing Respiratory Disease (eg chronic obstructive pulmonary disease, moderate bronchial asthma)
3. Chronic Renal Failure (creatinine clearance 15-30 ml / min).
4. Type 1 and/or diabetes mellitus with tissue damage (chronic renal failure, cardiovascular disease, retinopathy, chronic peripheral neuropathy – unless it falls into category B).
5. Nosocomial obesity BMI> 40.
6. Hemoglobinopathies (thalassemia homozygous, sickle cell anaemia).
7. Chronic liver failure Child-Pugh C. stage
8. Severe genetic coagulation disorders.
9. Neuromuscular diseases.
10. Pregnant women, regardless of gestational age, breastfeeding and breastfeeding.
Patients in the following categories are considered very high risk and recommended to work from home.
1. Pre-existing Chronic Respiratory Disease (eg severe bronchial asthma, patients on chronic oxygen therapy or non-invasive ventilation [CPAP or BiPaP] at home, severe pulmonary hypertension (NYHA III and IV), severe pulmonary fibrosis/lobectomy).
2. Severe Chronic Renal Failure (creatinine clearance <15 ml/min and hemodialysis).
3. Cardiac arrhythmia with a permanent defibrillator or heart disease with a permanent defibrillator and amphibole pacemaker.
4. Heart failure of any aetiology (ischemic or non-ischemic) stage according to NYHA III or IV.
5. Cardiovascular disease:
i. Recent acute coronary syndrome or vascular surgery: angioplasty or stent implantation in the last 12 months,
ii. Aortic-coronary bypass (CABG (bypass)) in the last 12 months,
iii. Recent AEE in the last 12 months or with established neurological semiology.
6. Myocardial infarction (History of documented myocarditis, hypertrophic, dilated, infiltrative (amyloidosis)).
7. Congenital heart disease after surgical correction with significant residual impairment or non-corrected congenital heart disease with significant residual impairment.
8. Active use of biological agents (eg TNF inhibitors, interleukin inhibitors) or other immunosuppressive drugs.
9. Active chronic corticosteroid administration (≥ 20mg prednisone or equivalent for ≥ 1 month).
10. Patients with a history of transplantation of solid organs or primordial hematopoietic cells.
11. Patients with co-morbid or haematological malignancies receiving chemotherapy or radiation or immunotherapy.
12. Patients with HIV or patients with CD4 lymphocyte count <200 / mm3.
13. Hereditary or acquired immunodeficiency.